WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 66.80
-0.20 (-0.30%)
Apr 20, 2026, 1:20 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.05 billion as of April 20, 2026. Its market cap has increased by 15.96% in one year.
Market Cap
3.05B
Enterprise Value
3.57B
Revenue
1.11B
Ranking
n/a
PE Ratio
14.81
Stock Price
66.80
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.05B, a decrease of -11.17%. That is a compound annual growth rate of -5.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.05B | -8.72% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hi-Clearance | 6.05B |
| Delta Asia International | 6.00B |
| Bonraybio | 4.09B |
| Medimaging Integrated Solution | 2.89B |
| Dynamic Medical Technologies | 2.55B |
| A Plus Biotechnology | 2.49B |
| Applied BioCode | 2.34B |
| Wellell | 2.27B |